Healthcare provider profile · identity verified

John Fx Horan, DO

Family Practice · WARWICK, RI · NPI 1679567531

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	571	160
Alprazolam	Alprazolam	557	74
Atorvastatin Calcium	Atorvastatin Calcium	510	140
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	441	51
Amlodipine Besylate	Amlodipine Besylate	387	109
Hydrochlorothiazide	Hydrochlorothiazide	384	110
Omeprazole	Omeprazole	370	103
Levothyroxine Sodium	Levothyroxine Sodium	366	85
Metoprolol Succinate	Metoprolol Succinate	332	93
Clonazepam	Clonazepam	314	35
Metformin Hcl	Metformin Hcl	269	80
Gabapentin	Gabapentin	255	54
Metoprolol Tartrate	Metoprolol Tartrate	243	65
Albuterol Sulfate Hfa	Albuterol Sulfate	224	58
Furosemide	Furosemide	218	57
Lorazepam	Lorazepam	217	42
Glimepiride	Glimepiride	188	46
Oxycodone Hcl	Oxycodone Hcl	180	27
Diazepam	Diazepam	172	23
Meloxicam	Meloxicam	165	41
Eliquis	Apixaban	164	27
Losartan Potassium	Losartan Potassium	161	46
Allopurinol	Allopurinol	154	41
Ibuprofen	Ibuprofen	152	30
Citalopram Hbr	Citalopram Hydrobromide	137	23
Trazodone Hcl	Trazodone Hcl	137	32
Pantoprazole Sodium	Pantoprazole Sodium	132	36
Simvastatin	Simvastatin	128	35
Rosuvastatin Calcium	Rosuvastatin Calcium	120	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	117	21
Fluoxetine Hcl	Fluoxetine Hcl	101	21
Tamsulosin Hcl	Tamsulosin Hcl	100	31
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	98	13
Sertraline Hcl	Sertraline Hcl	98	26
Tramadol Hcl	Tramadol Hcl	89	17
Escitalopram Oxalate	Escitalopram Oxalate	84	23
Quetiapine Fumarate	Quetiapine Fumarate	83	12
Zolpidem Tartrate	Zolpidem Tartrate	80	16
Celecoxib	Celecoxib	71	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	21
Alendronate Sodium	Alendronate Sodium	67	17
Fluticasone Propionate	Fluticasone Propionate	67	24
Clopidogrel	Clopidogrel Bisulfate	66	19
Atenolol	Atenolol	63	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	13
Mirtazapine	Mirtazapine	63	14
Pravastatin Sodium	Pravastatin Sodium	57	15
Duloxetine Hcl	Duloxetine Hcl	54	17
Naproxen	Naproxen	54	12
Nystatin	Nystatin	54	11
Amitriptyline Hcl	Amitriptyline Hcl	53	16
Spironolactone	Spironolactone	53	13
Prednisone	Prednisone	52	42
Doxycycline Hyclate	Doxycycline Hyclate	49	40
Finasteride	Finasteride	46	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	suppressed
Potassium Chloride	Potassium Chloride	45	11
Jardiance	Empagliflozin	43	12
Symbicort	Budesonide/Formoterol Fumarate	43	11
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Amoxicillin	Amoxicillin	42	32
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Spiriva Respimat	Tiotropium Bromide	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Methylprednisolone	Methylprednisolone	33	28
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	17
Diclofenac Sodium Er	Diclofenac Sodium	31	suppressed
Glipizide	Glipizide	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Linzess	Linaclotide	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	23
Tizanidine Hcl	Tizanidine Hcl	31	13
Alfuzosin Hcl Er	Alfuzosin Hcl	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Meclizine Hcl	Meclizine Hcl	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	23
Ezetimibe	Ezetimibe	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Famotidine	Famotidine	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Valsartan	Valsartan	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	12
Ozempic	Semaglutide	25	suppressed
Temazepam	Temazepam	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Azithromycin	Azithromycin	21	18
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Hydrocortisone	Hydrocortisone	21	13
Loperamide	Loperamide Hcl	21	suppressed
Creon	Lipase/Protease/Amylase	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Naloxone Hcl	Naloxone Hcl	16	15
Verapamil Er	Verapamil Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Baclofen	Baclofen	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Colestipol Hcl	Colestipol Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Colchicine	Colchicine	12	suppressed
Mupirocin	Mupirocin	12	11
Oxycontin	Oxycodone Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Vilazodone Hcl	Vilazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error